Patents by Inventor Timothy S. Daynard

Timothy S. Daynard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antiproliferative 1,2,3-thiadiazole compounds
    Patent number: 7022702
    Abstract: Pharmaceutical compositions and compounds are provided. The compounds of the invention have anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death. In one embodiment of the invention, formulations of the compounds in combination with a physiologically acceptable carrier are provided. The pharmaceutical formulations are useful in the treatment of hyperproliferative disorders, which disorders include tumor growth, lymphoproliferative diseases, angiogenesis.
    Type: Grant
    Filed: May 10, 2002
    Date of Patent: April 4, 2006
    Assignee: QLT Inc.
    Inventors: Zaihui Zhang, Gregory B. Chopiuk, Timothy S. Daynard, Shisen Wang
  • Antiproliferative 1,2,3-thiadiazole compounds
    Publication number: 20030096848
    Abstract: Pharmaceutical compositions and compounds are provided. The compounds of the invention have anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death. In one embodiment of the invention, formulations of the compounds in combination with a physiologically acceptable carrier are provided. The pharmaceutical formulations are useful in the treatment of hyperproliferative disorders, which disorders include tumor growth, lymphoproliferative diseases, angiogenesis.
    Type: Application
    Filed: May 10, 2002
    Publication date: May 22, 2003
    Inventors: Zaihui Zhang, Gregory B. Chopiuk, Timothy S. Daynard, Shisen Wang